NEWS

ISCT supports FDA stem-cell injunctions and proposes wider action to protect patients



ISCT supports FDA stem-cell injunctions and proposes wider action to protect patients

ISCT International Society Cell and Gene Therapy, the global professional society of clinicians, researchers, regulatory specialists, technologists and industry partners in the cell and gene therapy sector, today announces its reaction to the U.S. Food and Drug Administration (FDA) seeking court orders preventing two U.S. stem cell clinics administering unproven cellular therapy treatments to patients.
Full news here.